These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 1611637)

  • 1. Effect of propranolol and disopyramide on left ventricular function at rest and during exercise in hypertrophic cardiomyopathy.
    Hartmann A; Kühn J; Hopf R; Klepzig H; Standke R; Kober G; Maul FD; Hör G; Kaltenbach M
    Cardiology; 1992; 80(2):81-8. PubMed ID: 1611637
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Left ventricular function at rest and during exercise and the effects of propranolol in patients with hypertrophic cardiomyopathy].
    Amano K; Sakamoto T; Sugimoto T
    J Cardiol Suppl; 1987; 16():35-51. PubMed ID: 3509682
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disopyramide in hypertrophic cardiomyopathy. II. Noninvasive assessment after oral administration.
    Pollick C
    Am J Cardiol; 1988 Dec; 62(17):1252-5. PubMed ID: 3057852
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Diastolic ventricular function in hypertrophic, obstructive and non-obstructive cardiomyopathy--effect of gallopamil].
    Olbrich HG; Hopf R; Klepzig H; Hör G; Maul FD; Kaltenbach M
    Z Kardiol; 1989; 78 Suppl 5():29-35. PubMed ID: 2631478
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of acute reduction in left ventricular outflow tract pressure gradient in obstructive hypertrophic cardiomyopathy by disopyramide versus pilsicainide versus cibenzoline.
    Kajimoto K; Imai T; Minami Y; Kasanuki H
    Am J Cardiol; 2010 Nov; 106(9):1307-12. PubMed ID: 21029829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disopyramide in hypertrophic cardiomyopathy. I. Hemodynamic assessment after intravenous administration.
    Pollick C; Kimball B; Henderson M; Wigle ED
    Am J Cardiol; 1988 Dec; 62(17):1248-51. PubMed ID: 3195486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Comparative study of the effects of verapamil and propranolol therapy in 16 cases of obstructive hypertrophic myocardiopathy].
    Cosnay P; Fauchier JP; Lang M; Casset D; Raynaud P; Lavigne G; Itti R
    Arch Mal Coeur Vaiss; 1987 Mar; 80(3):346-55. PubMed ID: 3113357
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The acute response of left ventricular filling dynamics to intravenous verapamil predicts the changes in exercise tolerance after oral verapamil therapy in patients with hypertrophic cardiomyopathy.
    Tendera M; Schneeweiss A; Bartoszewski A; Polonski L; Wodniecki J; Salamon A
    Eur Heart J; 1993 Mar; 14(3):410-5. PubMed ID: 8458363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Salutary effect of disopyramide on left ventricular diastolic function in hypertrophic obstructive cardiomyopathy.
    Matsubara H; Nakatani S; Nagata S; Ishikura F; Katagiri Y; Ohe T; Miyatake K
    J Am Coll Cardiol; 1995 Sep; 26(3):768-75. PubMed ID: 7642872
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of verapamil and propranolol on left ventricular systolic function and diastolic filling in patients with coronary artery disease: radionuclide angiographic studies at rest and during exercise.
    Bonow RO; Leon MB; Rosing DR; Kent KM; Lipson LC; Bacharach SL; Green MV; Epstein SE
    Circulation; 1982 Jun; 65(7):1337-50. PubMed ID: 7074794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination of disopyramide and propranolol in hypertrophic cardiomyopathy.
    Cokkinos DV; Salpeas D; Ioannou NE; Christoulas S
    Can J Cardiol; 1989; 5(1):33-6. PubMed ID: 2920304
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute dose-response effects of intravenous disopyramide in hypertrophic obstructive cardiomyopathy.
    Kimball BP; Bui S; Wigle ED
    Am Heart J; 1993 Jun; 125(6):1691-7. PubMed ID: 8498312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Normalized left ventricular filling indexes to detect diastolic dysfunction in hypertension and in hypertrophic cardiomyopathy.
    Nakata T; Noto T; Uno K; Tanaka S; Tsuda T; Kubota M; Iimura O
    Can J Cardiol; 1991 Oct; 7(8):350-6. PubMed ID: 1742669
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of intravenous disopyramide on coronary hemodynamics and vasodilator reserve in hypertrophic obstructive cardiomyopathy.
    Hongo M; Nakatsuka T; Takenaka H; Tanaka M; Watanabe N; Yazaki Y; Sekiguchi M
    Cardiology; 1996; 87(1):6-11. PubMed ID: 8631046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of extent and distribution of left ventricular hypertrophy on clinical aspects and hemodynamics of patients with hypertrophic obstructive cardiomyopathy].
    Schwartzkopff B; Schwammenthal E; Lösse B; Steeg M; Strauer BE
    Z Kardiol; 1992 Jan; 81(1):15-24. PubMed ID: 1570724
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of concurrent oral administration of propranolol and disopyramide on cardiac function in healthy men.
    Cathcart-Rake WF; Coker JE; Atkins FL; Huffman DH; Hassanein KM; Shen DD; Azarnoff DL
    Circulation; 1980 May; 61(5):938-45. PubMed ID: 7363436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Doppler and echocardiographic assessments of effects of disopyramide on non-obstructive hypertrophic cardiomyopathy].
    Nagashima J
    J Cardiol; 1991; 21(1):75-86. PubMed ID: 1817183
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hypertrophic obstructive cardiomyopathy: spontaneous course in comparison to long-term therapy with propranolol and verapamil].
    Haberer T; Hess OM; Jenni R; Krayenbühl HP
    Z Kardiol; 1983 Sep; 72(9):487-93. PubMed ID: 6415946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral verapamil effects on global and regional left ventricular diastolic filling in hypertrophic cardiomyopathy.
    Yamagishi T; Ozaki M; Kusukawa R
    Jpn Circ J; 1990 Nov; 54(11):1365-73. PubMed ID: 2287041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of disopyramide on left ventricular pressure gradient in hypertrophic obstructive cardiomyopathy in comparison with propranolol--a case report.
    Tokudome T; Mizushige K; Ueda T; Sakamoto S; Matsuo H
    Angiology; 1999 Apr; 50(4):331-5. PubMed ID: 10225470
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.